Physician
Pulaski Medical Urgent Care, P.C
Pulaski Medical Urgent Care, P.C was paid $2.90M by Medicaid between Jan 2018 and Dec 2024, across 24 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 59% of everything it billed.
33Billing provider infoPULASKI MEDICAL URGENT CARE, P.C
PULASKI, NY 13142
PULASKI, NY 13142
33aNPI1568829356assigned 01/25/2016
33bProvider typeFamily Medicine Physician
28Total paid$2.90M
24GClaims63,046
24DCodes billed24
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#54 of 2,605
Median peer was paid$10K
This provider vs. median287×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,601 | $250K | |
| 2019 | 6,073 | $236K | |
| 2020 | 5,517 | $218K | |
| 2021 | 14,213 | $656K | |
| 2022 | 11,328 | $602K | |
| 2023 | 9,619 | $484K | |
| 2024incomplete | 9,695 | $452K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 59% | 27,086 | 25,804 | $1.72M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13% | 4,529 | 4,521 | $365K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.8% | 3,496 | 3,380 | $198K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 6.3% | 1,897 | 1,857 | $184K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.8% | 3,834 | 3,753 | $139K |
| 99051 | 2.8% | 8,172 | 8,028 | $80K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.3% | 3,549 | 3,433 | $66K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.7% | 2,777 | 2,725 | $50K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 2,535 | 1,324 | $30K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 674 | 669 | $21K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 430 | 426 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,264 | 1,241 | $6K |
12 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 384 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 298 | $5K |
| 87807 | <1% | 403 | $4K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 80 | $2K |
| 99050 | <1% | 198 | $2K | |
| 81002 | <1% | 1,032 | $2K | |
| 87634 | <1% | 37 | $689.72 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 29 | $351.27 |
| 81025 | <1% | 205 | $336.16 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 78 | $74.35 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 26 | $16.04 |
| 99000 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSULLIVAN, JAY (OWNER)